Pre-eclampsia and Future Cardiovascular Health: An Underused Opportunity to Improve Family Health (FINNCARE)
14. prosince 2020 aktualizováno: Tiina Jääskeläinen, Helsinki University Central Hospital
Background: PE (pre-eclampsia) is a common pregnancy-specific vascular hypertensive disease affecting 3-5% of pregnancies. PE independently increases the risk for premature cardiovascular disease (CVD) in mothers and their offspring long-term. PE provides a unique window for early risk profiling and CVD prevention. However, the efficacy of a family oriented lifestyle intervention to lower CVD risk in families with history of PE has not previously been evaluated.
Aim: This study will explore the impact of PE on CVD progression 8-12 years from delivery in mothers and their children, and assess whether a lifestyle intervention is useful for lowering mother and child blood pressure and improving the CVD risk profile overall in families with a history of PE.
Hypothesis: PE is related with CVD progression mediated by elevated blood pressure. Blood pressure and the CVD risk profile overall is modifiable in mothers and children by a 12-month behavioral lifestyle intervention in families with a history of PE.
Study design: Randomized controlled behavioral lifestyle intervention trial where families (mother, child and father from the FINNPEC study) are offered the opportunity to participate in a lifestyle intervention program 8-12 years after a PE pregnancy. 300 PE families will be randomized 1:1 to a 12-month lifestyle intervention program or to a control group. A parallel group of 100 non-PE control families will be assessed at baseline and follow-up.
Main outcome: 24 hour mean blood pressure change between baseline and follow-up in mother and child.
Significance: This study will provide information on CVD progression in mothers and children 8-12 years from a PE pregnancy. Furthermore, the study assess the effect of a 12-month lifestyle intervention on blood pressure and CVD risk profile overall following a PE pregnancy. Potentially, the study provides the opportunity to identify PE families at highest risk of CVD progression and families amenable to blood pressure and CVD risk profile improvement.
Přehled studie
Postavení
Nábor
Intervence / Léčba
Detailní popis
Power analysis:
Power calculations were performed in order to detect 5.5 mmHg reduction in maternal systolic blood pressure with a power of 80% and a 2-sided p-value of 0.05 for the difference between the groups (intervention and control PE) (NICE 2011). Accounting for a 20% loss to follow-up or missing data, a sample of 148 women in the PE intervention group and 148 women in the PE control group is needed.
Specific objectives:
- To assess cardiovascular health and CVD progression in families (mother, child and father) 8-12 years following a PE pregnancy compared with non-PE control families.
- To assess the effectiveness of a behavioral 12-month lifestyle intervention in mothers and their children 8-12 years following a PE pregnancy to lower blood pressure and improve their CVD risk profile overall.
- To assess the effectiveness of a lifestyle intervention on the awareness of CVD risk after a PE pregnancy.
Typ studie
Intervenční
Zápis (Očekávaný)
400
Fáze
- Nelze použít
Kontakty a umístění
Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.
Studijní kontakt
- Jméno: Tiina Jääskeläinen, PhD
- Telefonní číslo: +358 50 4150274
- E-mail: tiina.j.jaaskelainen@helsinki.fi
Studijní záloha kontaktů
- Jméno: Taisto Sarkola, PhD, MD
- Telefonní číslo: +358504274971
- E-mail: taisto.sarkola@hus.fi
Studijní místa
-
-
-
Helsinki, Finsko, 00029
- Nábor
- Helsinki university hospital
-
Kontakt:
- Taisto Sarkola, PhD, MD
- Telefonní číslo: +358504274971
- E-mail: taisto.sarkola@hus.fi
-
-
Kritéria účasti
Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dítě
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Ano
Pohlaví způsobilá ke studiu
Všechno
Popis
Inclusion Criteria:
Families are recruited from the FINNPEC cohort. In FINNPEC, PE was defined as hypertension and proteinuria occurring after 20 weeks gestation (American College of Obstetricians and Gynecologists 2002 criteria). Hypertension was defined as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg. Proteinuria was defined as urinary excretion of ≥0.3 g protein in a 24-hour specimen, or 0.3 g/L, or two ≥1+ readings on a dipstick in a random urine determination with no evidence of a urinary tract infection. Each PE diagnosis was ascertained based on hospital records and confirmed independently by a research nurse and a study physician in the original FINNPEC case-control study including 1450 nulliparous or multiparous women with a singleton pregnancy with PE and 1065 pregnant control women without PE (aged 18-47 years) from all 5 university hospitals in Finland during 2008-2011.
Exclusion criteria in the FINNPEC: multiple pregnancy, inability to speak Finnish or Swedish.
Exclusion Criteria in the FINNCARE:
- Pregnancy and/or lactation (for all mothers)
- Pre-eclampsia in any previous or subsequent pregnancies (for all non-PE mothers)
Studijní plán
Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.
Jak je studie koncipována?
Detaily designu
- Primární účel: Prevence
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: PE intervention
A 12-month lifestyle intervention program to improve mothers and their children blood pressure and CVD risk profile.
|
Families are provided at baseline with one 60 min face-to-face dietary counseling session with nutritionist using family-oriented motivational interviewing and solution focusing techniques.
The intervention continues in an interactive web-based portal where different modules include assignments, activities, and tests and related videos targeting five cardiovascular health-linked behaviors: 1) improving quality of fat in the diet, 2) increasing the consumption of foods rich in fiber, 3) decreasing the use of salt, 4) increasing physical activity and 5) reducing smoking.
|
|
Žádný zásah: PE control
The control group continue habitual lifestyle but will perform the same baseline and follow-up measurements as the intervention group.
They will be given general written information on healthy eating.
|
|
|
Žádný zásah: Non-PE control
The control group continue habitual lifestyle but will perform the same baseline and follow-up measurements as the intervention group.
They will be given general written information on healthy eating.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Blood pressure (mothers)
Časové okno: baseline -12 months
|
mean 24 hour ambulatory systolic BP and diastolic BP; mmHg
|
baseline -12 months
|
|
Blood pressure (children)
Časové okno: baseline -12 months
|
mean 24 hour ambulatory systolic BP and diastolic BP; mmHg
|
baseline -12 months
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Blood pressure 24 hour variability (mothers)
Časové okno: baseline -12 months
|
nocturnal systolic and diastolic BP dip; standard deviation of systolic and diastolic BP; weighted standard deviation of systolic and diastolic BP; mmHg
|
baseline -12 months
|
|
Arterial stiffness (mothers)
Časové okno: baseline -12 months
|
carotid-femoral pulse wave velocity; m/s
|
baseline -12 months
|
|
Adiposity (mothers)
Časové okno: baseline -12 months
|
BMI; kg/m2
|
baseline -12 months
|
|
Adiposity (mothers)
Časové okno: baseline -12 months
|
waist-hip-ratio (no unit)
|
baseline -12 months
|
|
Adiposity (mothers)
Časové okno: baseline -12 months
|
body fat percentage; %
|
baseline -12 months
|
|
Dietary intake (mothers)
Časové okno: baseline -12 months
|
food frequency questionnaire on quality of fat (SFA, MUFA and PUFA; E%/day)
|
baseline -12 months
|
|
Dietary intake (mothers)
Časové okno: baseline -12 months
|
food frequency questionnaire on fiber intake; g/day
|
baseline -12 months
|
|
Dietary intake (mothers)
Časové okno: baseline -12 months
|
food frequency questionnaire on salt intake; g/d
|
baseline -12 months
|
|
Physical activity and sedentary behavior (mothers)
Časové okno: baseline -12 months
|
questionnaire data: weekly number of sessions and minutes of moderate-to-vigorous-intensity physical activity and walking
|
baseline -12 months
|
|
Physical activity and sedentary behavior (mothers)
Časové okno: baseline -12 months
|
questionnaire data: meeting physical activity recommendations
|
baseline -12 months
|
|
Physical activity and sedentary behavior (mothers)
Časové okno: baseline -12 months
|
questionnaire data: daily minutes of sitting on a non-weekend and weekend day
|
baseline -12 months
|
|
Physical activity and sedentary behavior (mothers)
Časové okno: baseline -12 months
|
accelerometer data: daily number of steps
|
baseline -12 months
|
|
Physical activity and sedentary behavior (mothers)
Časové okno: baseline -12 months
|
accelerometer data: daily minutes of total and intensity-specific physical activity
|
baseline -12 months
|
|
Physical activity and sedentary behavior (mothers)
Časové okno: baseline -12 months
|
accelerometer data: daily minutes of stationary behavior
|
baseline -12 months
|
|
Physical activity and sedentary behavior (mothers)
Časové okno: baseline -12 months
|
accelerometer data: daily number of breaks in stationary behavior
|
baseline -12 months
|
|
Smoking (mothers)
Časové okno: baseline -12 months
|
questionnaire on status of smoking/use of snuf/use of electronic cigarettes/nicotine replacement therapy and number of cigarettes/day
|
baseline -12 months
|
|
Laboratory assessment of cardiovascular risk (mothers)
Časové okno: baseline -12 months
|
lipids (total cholesterol, LDL, HDL, triglycerides; mmol/l)
|
baseline -12 months
|
|
Laboratory assessment of cardiovascular risk (mothers)
Časové okno: baseline -12 months
|
hs-CRP; mg/l
|
baseline -12 months
|
|
Laboratory assessment of cardiovascular risk (mothers)
Časové okno: baseline -12 months
|
HOMA index calculated as glucose; mmol/l x insulin; mU/l / 22.5
|
baseline -12 months
|
|
Awareness of later life morbidity (mothers)
Časové okno: baseline -12 months
|
A brief questionnaire with true or false questions on pre-eclampsia and later life morbidity
|
baseline -12 months
|
|
Heart rate variability (mothers)
Časové okno: baseline -12 months
|
standard deviation of all R-R intervals; root mean square of successive R-R interval differences, ms; High frequency power of R-R intervals from spectral band 0.15-0.4
Hz, ms2 ;Low frequency power of R-R intervals from spectral band 0.04-0.15
Hz, ms2 ; and LF/HF ratio
|
baseline -12 months
|
|
Blood pressure 24 hour variability (children)
Časové okno: baseline -12 months
|
nocturnal systolic and diastolic BP dip; standard deviation of systolic and diastolic BP; weighted standard deviation of systolic and diastolic BP; mmHg
|
baseline -12 months
|
|
Arterial stiffness (children)
Časové okno: baseline -12 months
|
carotid-femoral pulse wave velocity; m/s
|
baseline -12 months
|
|
Adiposity (children)
Časové okno: baseline -12 months
|
BMI z-score
|
baseline -12 months
|
|
Adiposity (children)
Časové okno: baseline -12 months
|
waist-hip-ratio (no unit)
|
baseline -12 months
|
|
Adiposity (children)
Časové okno: baseline -12 months
|
body fat percentage; %
|
baseline -12 months
|
|
Dietary intake (children)
Časové okno: baseline -12 months
|
food frequency questionnaire derived data on SFA index, fiber index, salt index (sum of food items rich in SFA/fiber/salt used during the previous week)
|
baseline -12 months
|
|
Physical activity and sedentary behavior (children)
Časové okno: baseline -12 months
|
questionnaire data: weekly number of days and daily duration of active travel to school and hobbies, structured physical activity outside school hours, unstructured physical activity outside school hours, screen time sitting, non-screen time sitting Accelerometer data: daily number of steps; daily minutes of total and intensity-specific physical activity; daily minutes of and stationary behavior; meeting physical activity recommendations; daily number of breaks in stationary behavior
|
baseline -12 months
|
|
Physical activity and sedentary behavior (children)
Časové okno: baseline -12 months
|
questionnaire data: weekly number of days and daily duration of active travel to school and hobbies
|
baseline -12 months
|
|
Physical activity and sedentary behavior (children)
Časové okno: baseline -12 months
|
questionnaire data: structured physical activity outside school hours
|
baseline -12 months
|
|
Physical activity and sedentary behavior (children)
Časové okno: baseline -12 months
|
questionnaire data: unstructured physical activity outside school hours
|
baseline -12 months
|
|
Physical activity and sedentary behavior (children)
Časové okno: baseline -12 months
|
questionnaire data: screen time and non-screen time sitting
|
baseline -12 months
|
|
Physical activity and sedentary behavior (children)
Časové okno: baseline -12 months
|
accelerometer data: daily number of steps
|
baseline -12 months
|
|
Physical activity and sedentary behavior (children)
Časové okno: baseline -12 months
|
accelerometer data: daily minutes of total and intensity-specific physical activity
|
baseline -12 months
|
|
Physical activity and sedentary behavior (children)
Časové okno: baseline -12 months
|
accelerometer data: daily minutes of stationary behavior
|
baseline -12 months
|
|
Physical activity and sedentary behavior (children)
Časové okno: baseline -12 months
|
accelerometer data: meeting physical activity recommendations
|
baseline -12 months
|
|
Physical activity and sedentary behavior (children)
Časové okno: baseline -12 months
|
accelerometer data: daily number of breaks in stationary behavior
|
baseline -12 months
|
|
Laboratory assessment of cardiovascular risk (children)
Časové okno: baseline -12 months
|
lipids (total cholesterol, LDL, HDL, triglycerides; mmol/l)
|
baseline -12 months
|
|
Laboratory assessment of cardiovascular risk (children)
Časové okno: baseline -12 months
|
hs-CRP; mg/l
|
baseline -12 months
|
|
Laboratory assessment of cardiovascular risk (children)
Časové okno: baseline -12 months
|
HOMA index calculated as glucose; mmol/l x insulin; mU/l / 22.5
|
baseline -12 months
|
|
Process evaluation: reach
Časové okno: baseline
|
participation rate of the families recruited (research database on study visits)
|
baseline
|
|
Process evaluation: reach
Časové okno: baseline
|
representativeness of the families participating (parents' and children's age, questionnaire on socio-economics)
|
baseline
|
|
Process evaluation: compliance
Časové okno: baseline -12 months
|
participation rate in measurements (number of study visits and questionnaires completed)
|
baseline -12 months
|
|
Process evaluation: compliance
Časové okno: baseline -12 months
|
proportion of sessions completed in the web-based portal (data accumulated in the web-based portal)
|
baseline -12 months
|
|
Process evaluation: acceptability
Časové okno: baseline -12 months
|
usefulness and ease of use (questionnaire and proportion of webportal sessions completed by the families)
|
baseline -12 months
|
|
Process evaluation: acceptability
Časové okno: baseline -12 months
|
credibility and satisfaction of the web-based portal (questionnaire and proportion of webportal sessions completed by the families)
|
baseline -12 months
|
|
Process evaluation: acceptability
Časové okno: baseline -12 months
|
occurrence of technical problems (questionnaire)
|
baseline -12 months
|
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Arterial wall thickness (mothers)
Časové okno: baseline
|
intima-media thickness; common carotid, brachial and radial; mm
|
baseline
|
|
Left ventricular mass (mothers)
Časové okno: baseline
|
left ventricular mass; g
|
baseline
|
|
Left ventricular systolic function (mothers)
Časové okno: baseline
|
left ventricular global longitudinal strain; %
|
baseline
|
|
Left ventricular diastolic function (mothers)
Časové okno: baseline
|
left atrial volume; ml
|
baseline
|
|
Left ventricular diastolic function (mothers)
Časové okno: baseline
|
pulsed wave Doppler mitral early to late inflow velocity ratio (no unit)
|
baseline
|
|
Left ventricular diastolic function (mothers)
Časové okno: baseline
|
mitral lateral annular pulsed wave tissue Doppler early velocity; cm/s
|
baseline
|
|
Left ventricular diastolic function (mothers)
Časové okno: baseline
|
septal pulsed wave tissue Doppler early velocity; cm/s
|
baseline
|
|
Arterial wall thickness (children)
Časové okno: baseline
|
intima-media thickness; common carotid, brachial and radial; mm
|
baseline
|
|
Left ventricular mass (children)
Časové okno: baseline
|
left ventricular mass; g
|
baseline
|
|
Left ventricular systolic function (children)
Časové okno: baseline
|
left ventricular global longitudinal strain; %
|
baseline
|
|
Left ventricular diastolic function (children)
Časové okno: baseline
|
left atrial volume; ml
|
baseline
|
|
Left ventricular diastolic function (children)
Časové okno: baseline
|
pulsed wave Doppler mitral early to late inflow velocity ratio (no unit)
|
baseline
|
|
Left ventricular diastolic function (children)
Časové okno: baseline
|
mitral lateral annular pulsed wave tissue Doppler early velocity; cm/s
|
baseline
|
|
Left ventricular diastolic function (children)
Časové okno: baseline
|
septal pulsed wave tissue Doppler early velocity; cm/s
|
baseline
|
Spolupracovníci a vyšetřovatelé
Zde najdete lidi a organizace zapojené do této studie.
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Tiina Jääskeläinen, PhD, University of Helsinki
- Studijní židle: Hannele Laivuori, Prof, MD, University of Helsinki and University of Tampere
- Ředitel studie: Taisto Sarkola, PhD, MD, Helsinki University Central Hospital
Publikace a užitečné odkazy
Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.
Termíny studijních záznamů
Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.
Hlavní termíny studia
Začátek studia (Aktuální)
1. června 2019
Primární dokončení (Očekávaný)
1. prosince 2022
Dokončení studie (Očekávaný)
1. prosince 2024
Termíny zápisu do studia
První předloženo
7. prosince 2020
První předloženo, které splnilo kritéria kontroly kvality
14. prosince 2020
První zveřejněno (Aktuální)
21. prosince 2020
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
21. prosince 2020
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
14. prosince 2020
Naposledy ověřeno
1. prosince 2020
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- FINNCARE
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Ne
Studuje produkt zařízení regulovaný americkým úřadem FDA
Ne
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .